NanOlogy

NEWS

Business

Top 20 Life Science Startups to Watch in 2019

BioSpace is proud to present its NextGen Bio “Class of 2019,” a list of 20 up-and-coming life science companies in North America that launched* no earlier than 2017.

November 6, 2018

·

12 min read

·

IN THE PRESS

Drug Development

NanOlogy announces First Patient Enrolled in a Phase 1/2 Clinical Trial of NanoDoce® for Treatment of Bladder Cancer

April 9, 2019

·

4 min read

Job Trends

NanOlogy to Present Positive Preclinical Data for NanoDoce® in Treatment of Uro-Oncologic Cancers at 2019 Genitourinary Cancers (ASCO-GU) Symposium

February 13, 2019

·

4 min read

Job Trends

NanOlogy Chief Medical Officer on Panel to Discuss Next Wave of Innovation in IO Therapy at BIO CEO & Investor Conference

February 5, 2019

·

3 min read

Job Trends

Positive Preclinical Findings from Inhaled NanoPac® Lung Study Published in the Journal of Aerosol Medicine and Pulmonary Drug Delivery

October 30, 2018

·

3 min read

Drug Development

NanOlogy™ Completes Dose Escalation Portion of Phase 2 Clinical Trial of NanoPac® for Treatment of Prostate Cancer

April 30, 2018

·

5 min read

Lone Star Bio

NanOlogy to Update Clinical Program Transforming Treatment of Cancer at BIO CEO and Investor Conference

February 5, 2018

·

4 min read

Drug Development

NanOlogy Announces First Patient Enrolled in a Pancreatic Cancer Phase II Clinical Trial of NanoPac Adding to Trials in Prostate and Ovarian Cancers

December 18, 2017

·

4 min read

Drug Development

NanOlogy Announces First Patient Enrolled in a Phase II Clinical Trial of NanoPac for Treatment of Mucinous Cysts of the Pancreas

November 7, 2017

·

4 min read

Drug Development

Nanology Announces First Patient Enrolled In A Phase II Clinical Trial Of Nanopac For Treatment Of Prostate Cancer

October 16, 2017

·

5 min read

Drug Development

NanOlogy Enrolled First Patient in Ovarian Cancer Trial

October 10, 2017

·

3 min read

AWARDS

JOBS